MEP2408A - Trans-1-(6-hloro-3 fenilindan-1-1l)-3,3-dimetilpiperazin - Google Patents

Trans-1-(6-hloro-3 fenilindan-1-1l)-3,3-dimetilpiperazin

Info

Publication number
MEP2408A
MEP2408A MEP-24/08A MEP2408A MEP2408A ME P2408 A MEP2408 A ME P2408A ME P2408 A MEP2408 A ME P2408A ME P2408 A MEP2408 A ME P2408A
Authority
ME
Montenegro
Prior art keywords
phenylindan
dimethylpiperazine
chloro
trans
salts
Prior art date
Application number
MEP-24/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Benny Bang-Andersen
Klaus Peter Boegesoe
Klaus Gjervig Jensen
Henrik Svane
Allan Carsten Dahl
Mark Howells
Lars Ole Lyngsoe
Tomas Mow
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2004/000546 external-priority patent/WO2005016901A1/en
Publication of MEP2408A publication Critical patent/MEP2408A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MEP-24/08A 2003-08-18 2004-08-18 Trans-1-(6-hloro-3 fenilindan-1-1l)-3,3-dimetilpiperazin MEP2408A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301180 2003-08-18
DKPA200301305 2003-09-11
PCT/DK2004/000546 WO2005016901A1 (en) 2003-08-18 2004-08-18 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

Publications (1)

Publication Number Publication Date
MEP2408A true MEP2408A (xx) 2010-02-10

Family

ID=58707237

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-24/08A MEP2408A (xx) 2003-08-18 2004-08-18 Trans-1-(6-hloro-3 fenilindan-1-1l)-3,3-dimetilpiperazin

Country Status (15)

Country Link
KR (2) KR101227789B1 (sr)
CN (1) CN101935305B (sr)
AR (2) AR045278A1 (sr)
AT (1) ATE552247T1 (sr)
DK (1) DK1658277T3 (sr)
EA (2) EA200600443A1 (sr)
ES (1) ES2383369T3 (sr)
IS (1) IS8264A (sr)
ME (1) MEP2408A (sr)
MY (2) MY149089A (sr)
PT (1) PT1658277E (sr)
RS (3) RS53369B (sr)
SG (2) SG145723A1 (sr)
SI (1) SI1658277T1 (sr)
TW (2) TWI388550B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453198B (zh) * 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
PL3135656T3 (pl) 2011-06-20 2019-07-31 H. Lundbeck A/S Deuterowane 1-piperazyno-3-fenyloindany do leczenia schizofrenii
MX2021012248A (es) 2019-04-11 2022-03-11 Mei Pharma Inc Polimorfos de voruciclib y metodos de elaboracion y uso de los mismos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater

Also Published As

Publication number Publication date
SG148183A1 (en) 2008-12-31
IS8264A (is) 2006-01-26
TW200519098A (en) 2005-06-16
DK1658277T3 (da) 2012-06-18
TWI388550B (zh) 2013-03-11
KR20060066104A (ko) 2006-06-15
EA200600441A1 (ru) 2006-08-25
CN101935305A (zh) 2011-01-05
AR045279A1 (es) 2005-10-19
TW201111351A (en) 2011-04-01
SI1658277T1 (sl) 2012-10-30
CN101935305B (zh) 2013-04-10
EA014641B1 (ru) 2010-12-30
AR045278A1 (es) 2005-10-19
RS20060121A (sr) 2008-09-29
TWI403505B (zh) 2013-08-01
EA200600443A1 (ru) 2006-08-25
MY154535A (en) 2015-06-30
KR20060066094A (ko) 2006-06-15
ATE552247T1 (de) 2012-04-15
ES2383369T3 (es) 2012-06-20
HK1096089A1 (en) 2007-05-25
SG145723A1 (en) 2008-09-29
RS20060083A (sr) 2008-08-07
PT1658277E (pt) 2012-05-25
RS53369B (sr) 2014-10-31
MY149089A (en) 2013-07-15
HK1152699A1 (en) 2012-03-09
KR101227789B1 (ko) 2013-01-30

Similar Documents

Publication Publication Date Title
NO20061153L (no) Trans-1-(6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
MX2010004688A (es) Usos terapeuticos de compuestos que tienen actividad combinada de sert, 5- ht3 y 5-ht1a.
NO20090229L (no) 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte
GEP20084447B (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT1506185E (pt) Compostos novos e sua utilizacao
CY1111857T1 (el) Κρυσταλλικη βαση trans-1-((1r,3s)-6-xλωpo-3-φαινυλινδαν-1-υλο)-3,3-διμεθυλοπιπεραζινης
NO20074593L (no) Tartrat- og malatsalter av trans-1-(6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
GT200000034A (es) Compuestos y procedimientos para el tratamiento de asma, alergia y trastornos inflamatorios.
WO2002092072A3 (en) Drugs for the treatment of the alzheimer disease
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
AU2003260882A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
TW200716582A (en) Process for making a pharmaceutical compound
SG145723A1 (en) Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
UA89617C2 (en) Succinate and malonate salt of trans 4-(1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and use thereof as a medicament
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
SE0301442D0 (sv) Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
MY141048A (en) Morpholine derivatives as norepinephrine reuptake inhibitors
WO2005113526A3 (en) Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
SE0303075D0 (sv) 4-substituted imidazoles
CO5690574A2 (es) Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo
SE0202287D0 (sv) New compounds
UA101341C2 (ru) Терапевтические применения соединений, которые имеют комбинированную активность в отношении sert, 5-нт3 и 5-нт1a
HK1086754A (en) Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders